Twist Bioscience Corp. Forecast, price target & analysts
Why the stock moved Beta
Twist Bioscience Corp. Target price 2026 - Analyst rating & recommendation
Twist Bioscience Corp. Classifications & Recommendation
Twist Bioscience Corp. Price Target
| Target Price | $117.30 |
| Price | $159.78 |
| Deviation |
26.59%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Twist Bioscience Corp. 2027 .
The average Twist Bioscience Corp. target price is $117.30.
This is
26.59%
register free of charge
$155.40
2.74%
register free of charge
$45.45
71.55%
register free of charge
|
|
| A rating was issued by 16 analysts: 14 Analysts recommend Twist Bioscience Corp. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2027 of
26.59%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 376.57 | 465.42 |
| 20.32% | 23.59% | |
| EBITDA Margin | -29.59% | -10.33% |
| 35.91% | 65.08% | |
| Net Margin | -20.63% | -22.27% |
| 69.07% | 7.97% |
12 Analysts have issued a sales forecast Twist Bioscience Corp. 2026 . The average Twist Bioscience Corp. sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2026. The average Twist Bioscience Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Twist Bioscience Corp. Analysts have issued a net profit forecast 2026. The average Twist Bioscience Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Sep '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.30 | -1.65 |
| 63.89% | 26.92% | |
| P/E | negative | |
| EV/Sales | 22.24 |
13 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. EPS is
This results in the following potential growth metrics and future valuations:
Twist Bioscience Corp....
Current Twist Bioscience Corp. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Oct 08 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Oct 07 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Oct 01 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Sep 29 2026 |
| BWS Financial |
Locked
➜
Locked
|
Locked | Sep 18 2026 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| BWS Financial |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Oct 08 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Oct 07 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Oct 01 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Sep 29 2026 |
|
Locked
BWS Financial:
Locked
➜
Locked
|
Sep 18 2026 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
BWS Financial:
Locked
➜
Locked
|
Sep 09 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
